Discover 503 paid clinical trials in Louisville, Kentucky. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 503
Safety, Pharmacokinetics (PK), and Efficacy of ONC 841 in Advanced Solid Tumors
for
Advanced Solid Tumor
Location: Louisville KY, Ann Arbor MI, Philadelphia PA,
Sponsor: OncoC4, Inc.
Sex: All
Age: 18+
Code: NCT06352359
Phase 1, Recruiting
EXActDNA-003 / NSABP B-64: Study of Molecular Residual Disease Detection in Breast Cancer (MRD)
for
Breast Cancer
Location: Louisville KY, Edgewood KY, Newburgh IN, Kingsport TN,
Sponsor: Exact Sciences Corporation
Sex: All
Age: 18+
Code: NCT06401421
Recruiting
A Phase II Study Of Gliadel, Concomitant Temozolomide And Radiation, Followed By Dose Dense Therapy With Temozolomide Plus Bevacizumab For Newly Diagnosed Malignant High Grade Glioma
for
Glioma
Location: Louisville KY
Sponsor: Kentuckiana Cancer Institute
Sex: All
Age: 18 - 70+
Code: NCT00660621
Phase 2, Recruiting
Evaluation of RBS2418 in Subjects With Advanced, Metastatic Solid Tumors
for
Advanced Cancer
Location: Louisville KY, Nashville TN, Fairfax VA, Bethesda MD,
Sponsor: Riboscience, LLC.
Sex: All
Age: 18+
Code: NCT05270213
Phase 1, Recruiting
Phase 1/2 Study of Linvoseltamab in Adult Patients With Relapsed or Refractory Multiple Myeloma
for
Multiple Myeloma
Location: Louisville KY, Columbus OH, Atlanta GA, New York NY,
Sponsor: Regeneron Pharmaceuticals
Sex: All
Age: 18+
Code: NCT03761108
Phase 1, Phase 2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Study of Navtemadlin add-on to Ruxolitinib in JAK Inhibitor-Naïve Patients With Myelofibrosis Who Have a Suboptimal Response to Ruxolitinib
A Trial to Find Out if REGN4336 is Safe and How Well it Works Alone and in Combination With REGN5678 for Adult Participants With Advanced Prostate Cancer
for
Metastatic Castration-resistant Prostate Cancer
Location: Louisville KY, Columbus OH, Charlotte NC, Milwaukee WI,
Sponsor: Regeneron Pharmaceuticals
Sex: Male
Age: 18+
Code: NCT05125016
Phase 1, Phase 2, Recruiting
A Study of ASP1002 in Adults for Treatment of Solid Tumors
for
Advanced Solid Tumors
Location: Louisville KY, Cleveland OH, Detroit MI, Iowa City IA,
Sponsor: Astellas Pharma Global Development, Inc.
Sex: All
Age: 18+
Code: NCT05719558
Phase 1, Recruiting
The Safety and Pharmacokinetics Preliminary Efficacy of IMP7068 in Patients With Advanced Solid Tumors
for
Advanced Solid Tumors
Location: Louisville KY, Atlanta GA, Fairway KS, Dallas TX,
Sponsor: Impact Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT04768868
Phase 1, Recruiting
Evaluation of Lasofoxifene Combined With Abemaciclib Compared With Fulvestrant Combined With Abemaciclib in Locally Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation
for
Metastatic Breast Cancer
Location: Louisville KY, Columbus OH, St Louis MO, Cleveland OH,
Sponsor: LeonaBio
Sex: All
Age: 18+
Code: NCT05696626
Phase 3, Recruiting
Safety and Tolerability Study of GIM-122 in Subjects With Advanced Solid Malignancies
for
Advanced Solid Malignancies
Location: Louisville KY, Nashville TN, Richmond VA,
Sponsor: Georgiamune Inc
Sex: All
Age: 18+
Code: NCT06028074
Phase 1, Phase 2, Recruiting
A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma
Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)
for
Solid Tumor, Non-Small Cell Lung Cancer, Head and Neck Cancer,
Location: Louisville KY, Detroit MI, Milwaukee WI, Iowa City IA,
Sponsor: Inhibrx Biosciences, Inc
Sex: All
Age: 18+
Code: NCT04198766
Phase 1, Phase 2, Recruiting
A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma
for
Multiple Myeloma
Location: Louisville KY, Cincinnati OH, Indianapolis IN,